share_log

莱美药业(300006.SZ):参股公司广西阿格莱雅目前未进行阿尔茨海默病蛋白质药物的相关研究

Laimei Pharmaceutical (300006.SZ): The participating company Guangxi Agleya is currently not conducting research on protein drugs for Alzheimer's disease

Gelonghui Finance ·  May 14 03:09

Gelonghui, May 14 | Laimei Pharmaceutical (300006.SZ) said on the investor interactive platform that the company's shareholding company, Guangxi Aglaia, has not currently conducted research on protein drugs for Alzheimer's disease.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment